Pascal Hammel
Villejuif, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 188 publications
Impact of Tumor Genomic Profile on Adjuvant Chemotherapy Efficacy in Resected Pancreatic Adenocarcinoma: Results From the PRODIGE-24/CCTG PA6 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 03, 2026
Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 27, 2026
ASO Visual Abstract: Is R1 Extended Liver Resection for Locally Advanced Intrahepatic Cholangiocarcinoma Justified? Nodal Status Not Margin Drives Prognosis.
Journal: Annals of surgical oncology
Published: July 06, 2026
Emergency integrative supportive care program for frail patients with advanced pancreatic cancer: A prospective GERCOR ARCAD study.
Journal: medRxiv : the preprint server for health sciences
Published: July 03, 2026
Is Cytoreductive surgery for unresectable colorectal liver metastases able to improve patient outcome? Results of a pilot prospective study.
Journal: Cancer treatment reviews
Published: June 18, 2026
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.
Journal: The New England journal of medicine
Published: June 01, 2026
Deep Learning of Histopathology Predicts Outcomes After Surgery for Pancreatic Cancer.
Journal: JCO clinical cancer informatics
Published: April 29, 2026
Mapping National Definitions, Classifications, and Policy Approaches to Poor-Prognosis Cancers Across the G7 Cancer Initiative Countries.
Journal: JCO global oncology
Published: April 23, 2026
Is R1 Extended Liver Resection for Locally Advanced Intrahepatic Cholangiocarcinoma Justified? Nodal Status Not Margin Drives Prognosis.
Journal: Annals of surgical oncology
Published: April 22, 2026
Clinical implications and biomarkers in the PACT-21 CASSANDRA trial.
Journal: Lancet (London, England)
Published: November 26, 2025
TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 04, 2025
The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer.
Journal: The Lancet. Oncology
Published: September 25, 2025
Last Updated: 09/26/2026